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Accepted 2 May 2013AbstractObjective: To present a prenatal diagnosis of familial tuberous sclerosis complex (TSC).
Case Report: A 29-year-old woman was referred to our institution for amniocentesis at 24 weeks of gestation because of congenital anomaly.
The fetus had been found to have an intrathoracic echogenic mass, suspicious of type III congenital cystic adenomatoid malformation of the lung
(CCAML). The woman presented with a medical history of epilepsy and had received anticonvulsants but did not disclose the disease entity
associated with the epilepsy. Amniocentesis revealed a karyotype of 46,XX. A fetal ultrasound examination at 26 weeks of gestation reported the
diagnosis of type III CCAML. At 30 weeks of gestation, magnetic resonance imaging showed multiple cortical tubers in the brain along with an
intracardiac mass suspicious of cardiac rhabdomyoma, and a diagnosis of fetal TSC was made. A prenatal ultrasound examination at 30 weeks of
gestation revealed multiple cardiac tumors and multiple cortical tubers in the brain. The mother admitted that she had been diagnosed to have
TSC. Molecular analysis of the cultured amniocytes and the parental blood showed a splicing mutation of c.2639þ1G>C in the splice donor site
of intron 22 of TSC2 gene in the mother and the fetus.
Conclusion: Prenatal diagnosis of an intrathoracic lesion with a family history of parental epilepsy should raise a suspicion of fetal cardiac
rhabdomyoma and TSC, and prompt magnetic resonance imaging investigation and molecular genetic analysis if necessary.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Fig. 1. (A, B) Prenatal ultrasound at 23 weeks of gestation shows a
1.96 cm  0.99 cm echogenic mass (arrow) in the lower lung lobe between the
diaphragm and the fetal heart.
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Tuberous sclerosis complex (TSC) is an autosomal domi-
nant disorder that can be associated with major features of
facial angiofibromas, ungual or periungual fibromas, hypo-
melanotic macules, shagreen patch, multiple retinal nodular
hamartomas, cortical tuber, subependymal nodule or giant cell
astrocytoma, cardiac rhabdomyoma, lymphangiomyomatosis
and renal angiomyolipoma, and minor features of dental
enamel pits, hamartomatous rectal polyps, bone cysts, cerebral
white matter radial migration lines, gingival fibromas, non-
renal hamartoma, retinal achromic patch, confetti skin lesions,
and multiple renal cysts [1]. Two major features or one major
feature plus two minor features definite TSC [1].
TSC is caused by mutations of tumor suppressor genes of
TSC1 (OMIM 605284), which maps to 9q34 and encodes
hamartin, and TSC2 (OMIM 191092), which maps to 16p13.3
and encodes tuberin. Approximately 85% of the patients with
definite TSC can be identified to have TSC1 and TSC2 muta-
tions, of which TSC1 mutations account for 31% and TSC2
mutations account for 69% [1]. In the Taiwanese population,
TSC1 or TSC2mutations have been identified mutations in 76%
of the patients (64/84), and among thesemutations, 86% (55/64)
have been TSC2 mutations and 14% (9/64) have been TSC1
mutations [2]. Hung et al [2] found that in Taiwanese TSC
families, the clinical manifestations caused by TSC2 mutations
are more severe than those caused by TSC1 mutations.
With the advent of fetal ultrasound and magnetic resonance
imaging (MRI), cardiac rhabdomyomas and cerebral tubers can
be diagnosed in the late 2nd trimester or in the 3rd trimester [3e8].
A prenatal diagnosis of TSC may lead to an incidental detection
of previously unknown familial inheritance.Here,we present our
experience of the detection ofmaternal transmission of a splicing
mutation in the TSC2 gene following a prenatal diagnosis of fetal
TSC and cardiac rhabdomyomas mimicking congenital cystic
adenomatoid malformation of the lung (CCAML), and aware-
ness of a family history of maternal epilepsy.
Case report
A 29-year-old, gravida 2, para 0, woman was referred to
our institution for amniocentesis at 24 weeks of gestation
because of congenital anomaly. At 23 weeks of gestation, the
fetus was found to have a 1.96 cm  0.99 cm intrathoracic
echogenic mass, suspicious of type III CCAML (Fig. 1). Her
husband was 29 years old, and there was no family history of
congenital malformation. The woman presented with a medi-
cal history of epilepsy and had received anticonvulsants since
the age of 20 years. However, she did not disclose the disease
entity associated with the epilepsy. Amniocentesis revealed a
karyotype of 46,XX. A fetal ultrasound examination at 26
weeks of gestation detected a 2.2 cm  1.8 cm lesion in the
left lung lobe between the diaphragm and the fetal heart with
no feeding vessels, and a diagnosis of type III CCAML was
made (Fig. 2). She was referred to the radiological department
for evaluation of the intrathoracic mass by MRI at 30 weeks of
gestation. Fetal MRI showed multiple cortical tubers in thebrain along with an intracardiac mass suspicious of cardiac
rhabdomyoma, and a diagnosis of fetal TSC was made
(Fig. 3). A prenatal ultrasound examination at 30 weeks of
gestation revealed a 2.6 cm  2.25 cm mass between the heart
and the diaphragm, a 1.4 cm  1.09 cm mass in the right
ventricle near the apex, a 0.9 cm  0.4 cm mass in the right
ventricle near the tricuspid valve, and two cortical tubers in the
left frontal lobe and left temporal lobe, respectively (Fig. 4).
The findings were consistent with cardiac rhabdomyomas and
cerebral tubers. The mother subsequently admitted that she
had been diagnosed to have TSC with tubers in the brain and
kidneys by MRI and computed tomography examination
(Fig. 5). The mother did not show any manifestations of
mental retardation, cognitive disorders, or autism. Molecular
analysis of the cultured amniocytes and the parental blood
showed a splicing mutation of c.2639þ1G>C in the splice
donor site of intron 22 of the TSC2 gene in the mother and the
fetus (Fig. 6). The father did not have such a mutation.
Discussion
The present case shows that fetal cardiac rhabdomyoma
may mimic CCAML on prenatal ultrasound. The present case
Fig. 2. (A, B) Prenatal ultrasound at 26 weeks of gestation shows a
2.2 cm  1.8 cm solid mass (arrow) in the lower lung lobe between the dia-
phragm and the fetal heart.
417C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 415e419provides evidence that fetal MRI is a useful adjunct to ultra-
sound for the precise determination of the extent of cerebral
involvement in TSC in the presence of cardiac rhabdomyomas
[4,6,9,10]. We suggest that prenatal diagnosis of fetal CCAML
or intrathoracic tumor associated with a family history of
parental epilepsy should raise a suspicion of TSC, and prompt
fetal MRI investigation and molecular genetic analysis if
necessary. CCAML is one of the most common lung lesionsFig. 3. Fetal magnetic resonance imaging (MRI) at 30 weeks of gestation shows
(C) coronal scan.detected prenatally by ultrasound and is caused by abnor-
malities of branching morphogenesis of the lung [11].
CCAML has been classified into type I (macrocysts), type II
(mixed), and type III (microcysts) [12]. Type III CCAML
appears as a hyperechogenic, homogeneous solid mass
compared to the adjacent normal lung parenchymal tissue
[11]. Type III CCAML can result in complete intrauterine
resolution [13], and it has been estimated that up to 59% of the
cases of CCAML regress during the course of gestation [11].
Thepresent casemanifestedmultiple cardiac rhabdomyomas.
Cardiac rhabdomyomas are the most frequently reported sign in
fetuses or neonates affected with TSC [14e22]. A prenatal
diagnosis of cardiac tumor should raise suspicion for TSC.
Jo´zwiak et al [15] reported that 83.3% (20/24) of TSC children
younger than 2 years had cardiac rhabdomyomas. Tworetzky
et al [17] reported that 95.3% (61/64) of neonates and fetuses
with multiple cardiac tumors and 23.3% (7/30) of patients with a
single cardiac tumor had TSC. Niewiadomska-Jarosik et al [21]
reported that 100% (12/12) of fetuses with multiple cardiac tu-
mors and 9.1% (1/11) of patients with a single cardiac tumor had
TSC. Cardiac rhabdomyomas are benign in view of the cardio-
vascular outcome because most tumors regress beyond the 3rd
trimester, and there is a only 4e6% risk of fetal demise [14,16].
Chao et al [19] concluded that in cases of prenatally detected
cardiac rhabdomyomas, large tumor size and hydrops fetalis are
significantly associatedwith poor outcome, and a positive family
history and multiple cardiac tumors are associated with TSC.
Saada et al [20] concluded that detailed prenatal ultrasound ex-
amination and 3rd-trimester fetal MRI can diagnose most TSC
cerebral lesions but fail to determine the neurological outcome in
fetuses with prenatally detected rhabdomyomas. Yinon et al [23]
concluded that the long-term prognosis of prenatally detected
rhabdomyomas is determinedby the neurologicalmanifestations
associated with TSC. Lee et al [22] concluded that the outcome
of isolated cardiac rhabdomyoma is favorable, and suggested
that molecular genetic characterization of TSC1 and TSC2 is
helpful in predicting neurodevelopmental outcome in prenatally
diagnosed rhabdomyomas.
The present case manifested multiple cortical tubers. The
prognosis of TSC with prenatally detected cerebral lesions is
poor because, unlike rhabdomyomas, the cortical tubers do notmultiple cortical tubers (arrows). (A) Sagittal scan, (B) transaxial scan, and
Fig. 4. Prenatal ultrasound at 30 weeks of gestation shows (A) a 2.6 cm  2.25 cm solid mass between the heart and diaphragm, (B) a 1.4 cm  1.09 cm solid mass
in the right ventricle near the apex, (C) a 0.9 cm  0.4 cm solid mass in the right ventricle near the tricuspid valve, and (D) a cortical tuber in the left frontal lobe
(arrow).
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correlated with mental retardation, behavioral problems, in-
fantile spasms, intractable epilepsy, cognitive disabilities, and
autistic spectrum disorders [24e26]. In a study of 125 children
with TSC, Yates et al [27] found that 16.8% (21/125) were
identified prenatally, 91.2% (114/125) had epilepsy, and 64%
(80/125) had intellectual disability. Kassiri et al [26] found that
the total number and location of cortical tubers are associated
with the extent of mental retardation in patients with TSC.
The present case had a maternally transmitted inherited
splicingmutation in the TSC2 gene andwas associatedwith fetal
cardiac rhabdomyomas and cerebral tubers and maternal epi-
lepsy. TSC is inherited in an autosomal dominant pattern with a
50% risk of inheriting the mutation in the offspring from the
affected parent. Approximately, 1/3 of the cases with TSC are
familial, and 2/3 of the TSC cases are caused by a de novo eventFig. 5. Maternal computed tomography (CT) scan and MRI scan at the age of 20 ye
transaxial view of CT scan, and (B and C) multiple cortical tubers (arrows) at bil[1]. The splicing mutation of c.2639þ1G>C in intron 22 of
TSC2 in this case has previously been reported by Dabora et al
[28]. Compared with TSC1mutations, TSC2mutations result in
more cortical tubers, increased frequency of infantile spasms,
severe cognitive decline, and increased disease severity in the
patients [26,28,29]. Dabora et al [28] found that patients with
TSC1mutations hadmilder disease, lower frequency of seizures
and mental retardation, fewer subependymal nodules and
cortical tubers, less severe renal involvement, no retinal
hamartomas, and less severe facial angiofibromas when
compared with those with TSC2 mutations.
In summary, we present a rare case of maternally trans-
mitted TSC2 mutation with fetal rhabdomyomas mimicking
CCAML. Our presentation shows that prenatal MRI is useful
for the diagnosis of TSC with cerebral tubers. A prenatal
diagnosis of an intrathoracic lesion with a family history ofars shows (A) multiple calcified spots (arrows) on bilateral ventricular walls on
ateral frontal lobes on transaxial view of MRI scan.
Fig. 6. Molecular analysis shows a splicing mutation of c.2639þ1G>C in the
splice donor site of intron 22 of the TSC2 gene in the mother and the fetus.
WT ¼ wild type.
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cardiac rhabdomyomas and TSC. MRI investigation to detect
cerebral involvement and molecular genetic analysis to detect
mutations in TSC1 or TSC2 are recommended.
Acknowledgments
This work was supported by research grants NSC-99-2628-
B-195-001-MY3 and NSC-101-2314-B-195-011-MY3 from
the National Science Council and MMH-E-102-04 from
Mackay Memorial Hospital, Taipei, Taiwan.
References
[1] Northrup H, Koenig MK, Au K-S. Tuberous sclerosis complex. In:
Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. Gen-
eReviews [Internet]. Seattle, WA: University of Washington; 1993.
Available at, http://www.ncbi.nlm.nih.gov/books/NBK1220/. Update:
Nov 23, 2011. [accessed 13.04.13].
[2] Hung C-C, Su Y-N, Chien S-C, Liou H-H, Chen C-C, Chen P-C, et al.
Molecular and clinical analyses of 84 patients with tuberous sclerosis
complex. BMC Med Genet 2006;7:72.
[3] Chen C-P, Su Y-N, Hung C-C, Lee CN, Hsieh FJ, Chang TY, et al.
Molecular genetic analysis of the TSC genes in two families with pre-
natally diagnosed rhabdomyomas. Prenat Diagn 2005;25:176e8.
[4] Chen C-P, Liu Y-P, Huang J-K, Chang T-Y, Chen M-R, Chiu N-C, et al.
Contribution of ultrafast magnetic resonance imaging in prenatal diag-
nosis of sonographically undetected cerebral tuberous sclerosis associ-
ated with cardiac rhabdomyomas. Prenat Diagn 2005;25:523e4.
[5] Chen C-P, Su Y-N, Hung C-C, Shih J-C, Wang W. Novel mutation in the
TSC2 gene associated with prenatally diagnosed cardiac rhabdomyomas
and cerebral tuberous sclerosis. J Formos Med Assoc 2006;105:599e603.
[6] Chen C-P, Su Y-N, Chang T-Y, Liu Y-P, Tsai F-J, Hwang JK, et al.
Prenatal MRI and ultrasound imaging findings of concomitant rhabdo-
myomas and cerebral tuberous sclerosis. Taiwan J Obstet Gynecol
2009;48:327e31.
[7] Chen C-P, Su Y-N, Chang T-Y, Liu Y-P, Tsai F-J, Chen M-R, et al.
Prenatal diagnosis of rhabdomyomas and cerebral tuberous sclerosis by
magnetic resonance imaging in one fetus of a dizygotic twin pregnancy
associated with a frameshift mutation in the TSC2 gene. Taiwan J Obstet
Gynecol 2010;49:387e9.
[8] Chen C-P, Su Y-N, Hsu C-Y, Chen M-R, Liu Y-P, Wu P-C, et al. Prenatal
diagnosis of cerebral tubers by magnetic resonance imaging following
detection of cardiac rhabdomyomas by prenatal ultrasound in a fetus witha nonsense mutation in the TSC2 gene. J Med Ultrasound
2011;19:68e70.
[9] Mirlesse V, Werner H, Jacquemard F, Perotez C, Daffos F, Sonigo P, et al.
Magnetic resonance imaging in antenatal diagnosis of tuberous sclerosis.
Lancet 1992;340:1163.
[10] Kivelitz DE, Mu¨hler M, Rake A, Scheer I, Chaoui R. MRI of cardiac
rhabdomyoma in the fetus. Pediatr Radiol 2004;14:1513e6.
[11] Tsai H-F, Cheng Y-C, Ko H-C, Kang L, Tsai P-Y, Yu C-H, et al. Prenatal
diagnosis of fetal congenital cystic adenomatoid malformation of the
lung using three-dimensional ultrasound: comparison between the 20th
and 21st centuries. Taiwan J Obstet Gynecol 2013;52:90e6.
[12] Adzick NS, Harrison MR, Crombleholme TM, Flake AW, Howell LJ.
Fetal lung lesions: management and outcome. Am J Obstet Gynecol
1998;179:884e9.
[13] Hsu K-F, Wu M-H, Chang C-H, Yao B-L, Chang F-M. Complete intra-
uterine resolution of fetal congenital cystic adenomatoid malformation of
the lung type III. J Ultrasound Med 1995;14:871e5.
[14] Holley DG, Martin GR, Brenner JI, Fyfe DA, Huhta JC, Kleinman CS,
et al. Diagnosis and management of fetal cardiac tumors: a multicenter
experience and review of published reports. J Am Coll Cardiol
1995;26:516e20.
[15] Jo´zwiak S, Schwartz RA, Janniger CK, Bielicka-Cymerman J. Useful-
ness of diagnostic criteria of tuberous sclerosis complex in pediatric
patients. J Child Neurol 2000;15:652e9.
[16] Bader RS, Chitayat D, Kelly E, Ryan G, Smallhorn JF, Toi A, et al. Fetal
rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of
associated tuberous sclerosis complex. J Pediatr 2003;143:620e4.
[17] TworetzkyW, McElhinney DB, Margossian R, Moon-Grady AJ, Sallee D,
Goldmuntz E, et al. Association between cardiac tumors and tuberous
sclerosis in the fetus and neonate. Am J Cardiol 2003;92:487e9.
[18] Jo´zwiak S, Kotulska K. Are all prenatally diagnosed multiple cardiac
rhabdomyomas a sign of tuberous sclerosis? Prenat Diagn 2006;26:867e9.
[19] Chao AS, Chao A, Wang TH, Chang YC, Chang YL, Hsieh CC, et al.
Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and
a meta-analysis. Ultrasound Obstet Gynecol 2008;31:289e95.
[20] Saada J, Hadj Rabia S, Fermont L, Le Bidois J, Bernardes LS,
Martinovic J, et al. Prenatal diagnosis of cardiac rhabdomyomas: inci-
dence of associated cerebral lesions of tuberous sclerosis complex. Ul-
trasound Obstet Gynecol 2009;34:155e9.
[21] Niewiadomska-Jarosik K, Stanczyk J, Janiak K, Jarosik P, Moll JJ,
Zamojska J, et al. Prenatal diagnosis and follow-up of 23 cases of cardiac
tumors. Prenat Diagn 2010;30:882e7.
[22] Lee KA, Won H-S, Shim J-Y, Lee PR, Kim A. Molecular genetic, cardiac
and neurodevelopmental findings in cases of prenatally diagnosed
rhabdomyoma associated with tuberous sclerosis complex. Ultrasound
Obstet Gynecol 2013;41:306e11.
[23] Yinon Y, Chitayat D, Blaser S, Seed M, Amsalem H, Yoo S-J, et al. Fetal
cardiac tumors: a single-center experience of 40 cases. Prenat Diagn
2010;30:941e9.
[24] Wortmann SB, Reimer A, Creemers JWT, Mullaart RA. Prenatal diag-
nosis of cerebral lesions in Tuberous sclerosis complex (TSC). Case
report and review of the literature. Eur J Paediatr Neurol 2008;12:123e6.
[25] Orlova KA, Crino PB. The tuberous sclerosis complex. Ann NYAcad Sci
2010;1184:87e105.
[26] Kassiri J, Snyder TJ, Bhargava R, Wheatley BM, Sinclair DB. Cortical
tubers, cognition, and epilepsy in tuberous sclerosis. Pediatr Neurol
2011;44:328e32.
[27] Yates JRW, Maclean C, Higgins JNP, Humphrey A, le Mare´chal K,
Clifford M, et al. The tuberous sclerosis 2000 study: presentation, initial
assessments and implications for diagnosis and management. Arch Dis
Child 2011;96:1020e5.
[28] Dabora SL, Jo´zwiak S, Franz DN, Roberts PS, Nieto A, Chung J, et al.
Mutational analysis in a cohort of 224 tuberous sclerosis patients in-
dicates increased severity of TSC2, compared with TSC1, disease in
multiple organs. Am J Hum Genet 2001;68:64e80.
[29] Doherty C, Goh S, Poussaint TY, Erdag N, Thiele EA. Prognostic sig-
nificance of tuber count and location in tuberous sclerosis complex. J
Child Neurol 2005;20:837e41.
